← Leaderboards
Hibiki Fujita
Weill Medical Coll Of Cornell Univ
$1,130,230
Attributed
$2,181,161
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $826.7K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,181,161 · 3
By mechanism
R01$1,635,738 · 1
R21$466,125 · 1
F31$79,298 · 1
Top collaborators
- David Eliezer2 shared
- Giovanni Manfredi2 shared
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Julie Magarian Blander$17,921,173
- Bobby Thomas$7,388,450
Others in their field
Top investigators on “Pathogenesis”
- Jeffrey P Krischer · University Of South Florida$473,867,135
- Constance Ann Benson · University Of California, San Diego$309,631,408
- Daniel R Kuritzkes · Brigham And Women'S Hospital$212,627,101
- Richard K. Wilson · Washington University$203,917,615
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$198,007,440
- Carol Nesel · Westat$147,274,423
Research focus
PathogenesisMolecularCellsMutationBiochemicalMutantMitochondriaPhenotypeAmyotrophic Lateral SclerosisProteinsMediatingPropertyPathogenicityPathway InteractionsAttenuatedLinkMouse ModelGenetic ApproachProtein FoldingMyopathyProductionBioenergeticsMitochondrial MembraneDefect
Grant awards (6)
CHCHD10 Frontotemporal Dementia, Molecular Mechanisms and Therapeutic Strategies$808,996
R01 · FY2025 · NS · contact PI
CHCHD10 Frontotemporal Dementia, Molecular Mechanisms and Therapeutic Strategies$826,742
R01 · FY2024 · NS · contact PI
Targeting astrocytic toxicity for ALS therapy$211,875
R21 · FY2019 · NS · contact PI
Targeting astrocytic toxicity for ALS therapy$254,250
R21 · FY2018 · NS · contact PI
The pathogenic mechanisms of mutant ANT1 myopathy$39,649
F31 · FY2007 · NS · contact PI
The pathogenic mechanisms of mutant ANT1 myopathy$39,649
F31 · FY2006 · NS · contact PI